Lifebit is a UK-headquartered technology company that has built its reputation on solving one of the most persistent problems in biomedical research: enabling scientists to analyse sensitive genomic and clinical data across organisational and national boundaries without moving the data itself. Its core platform centres on federated analytics, allowing researchers to run queries and models against siloed datasets held by hospitals, biobanks, and government health agencies while those datasets remain under the control of their custodians.
The company's CloudOS platform provides a cloud-agnostic environment for large-scale genomic data analysis, supporting bioinformatics pipelines built on open standards such as Nextflow and WDL. It has been adopted by national genome programmes, population health initiatives, and pharmaceutical research teams who need to interrogate biobank-scale data without breaching data-governance requirements. Lifebit's infrastructure is designed to handle the volume and sensitivity demands of population genomics, connecting data held across multiple institutions through a privacy-preserving layer.
Founded in London, the company has worked with public health bodies and research consortia across Europe and beyond, positioning itself at the intersection of data infrastructure, regulatory compliance, and biomedical discovery. Its tooling supports drug target identification, rare disease research, and translational science programmes that depend on access to large, linked datasets.
Further information is available at lifebit.ai.